Cancer Immunology Immunotherapy · 2020 · 93 citations · 31 references
MedicineOncologyPharmacotherapyImmunotherapyMolecular OncologyBiomarker-guided ImmunotherapyBiomarker-guided Therapy SelectionCancer ImmunotherapyImmune Checkpoint InhibitorsResponse AssessmentClinicopathologic FeaturesPathological CorrelatesPd-l1 BlockadePembrolizumab TherapyProgrammed Death-ligand 1 Biomarker
31
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations